The hypercholesterolemia market demonstrates steady advancement driven by increasing prevalence of cardiovascular diseases and evolving therapeutic interventions. Industry stakeholders are witnessing heightened demand for advanced lipid-lowering agents, reflecting broader market trends. These market dynamics are supported by robust innovation and expanding access to effective cholesterol...